Gene · 23091
Papers1,599
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,599
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Landscape analysis of m6A modification regulators related biological functions and immune characteristics in myasthenia gravis. | J Transl Med | 2023 | 36864526 | PubTator, text mining | PubMed |
| Identification of m6A regulator-mediated RNA methylation modification patterns and key immune-related genes involved in atrial fibrillation. | Aging (Albany NY) | 2023 | 36863715 | PubTator, text mining | PubMed |
| Systems Medicine for Precise Targeting of Glioblastoma. | Mol Biotechnol | 2023 | 36859639 | PubTator, text mining | PubMed |
| m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion. | Mol Cancer | 2023 | 36859310 | PubTator, text mining | PubMed |
| Caprin-1 plays a role in cell proliferation and Warburg metabolism of esophageal carcinoma by regulating METTL3 and WTAP. | J Transl Med | 2023 | 36855123 | PubTator, text mining | PubMed |
| The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications. | Exp Mol Med | 2023 | 36854773 | PubTator, text mining | PubMed |
| RNA-mediated heterochromatin formation at repetitive elements in mammals. | EMBO J | 2023 | 36847618 | PubTator, text mining | PubMed |
| A composite score based on immune-related gene prognostic index and m6A risk score of head and neck squamous cell carcinoma. | Front Genet | 2023 | 36845378 | PubTator, text mining | PubMed |
| Integrated single-cell and transcriptome sequencing analyses develops a metastasis-based risk score system for prognosis and immunotherapy response in uveal melanoma. | Front Pharmacol | 2023 | 36843929 | PubTator, text mining | PubMed |
| Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance. | Int J Mol Sci | 2023 | 36835633 | PubTator, text mining | PubMed |
| Understanding the Epitranscriptome for Avant-Garde Brain Tumour Diagnostics. | Cancers (Basel) | 2023 | 36831575 | PubTator, text mining | PubMed |
| RBM15 Promates the Proliferation, Migration and Invasion of Pancreatic Cancer Cell Lines. | Cancers (Basel) | 2023 | 36831430 | PubTator, text mining | PubMed |
| The Emerging Role of m6A Modification in Endocrine Cancer. | Cancers (Basel) | 2023 | 36831377 | PubTator, text mining | PubMed |
| Factors and Methods for the Detection of Gene Expression Regulation. | Biomolecules | 2023 | 36830673 | PubTator, text mining | PubMed |
| Critical Roles of METTL3 in Translation Regulation of Cancer. | Biomolecules | 2023 | 36830614 | PubTator, text mining | PubMed |
| m6A Modification-Association with Oxidative Stress and Implications on Eye Diseases. | Antioxidants (Basel) | 2023 | 36830067 | PubTator, text mining | PubMed |
| The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection. | Oxid Med Cell Longev | 2023 | 36819785 | PubTator, text mining | PubMed |
| A Prognostic Signature for Colon Adenocarcinoma Patients Based on m6A-Related lncRNAs. | J Oncol | 2023 | 36814559 | PubTator, text mining | PubMed |
| Emerging roles of m6A RNA modification in cancer therapeutic resistance. | Exp Hematol Oncol | 2023 | 36810281 | PubTator, text mining | PubMed |
| RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4. | Mol Med | 2023 | 36803098 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23091/papers?page=19